Los Angeles, CA, April 27, 2015 — Obesity has reached epidemic proportions affecting nearly 78 million adults in the United States and has been linked with an increased risk of diabetes, heart disease, and cancer. Recent studies have suggested that obese patients have specific amino acid deficiencies that can contribute to obesity.
The latest research report entitled “Nutritional Deficiencies Associated with Obesity,” published online in the Journal of Obesity and Weight Loss Therapy, highlights the specific amino acid and nutrient deficiencies that are commonly associated with obesity. The report summarizes current research into the distinct nutritional deficiencies associated with Obesity and establishes the need for both continued research and treatments that are focused on addressing the unique micronutrient and metabolic needs of obese patients.
“Obesity is a major concern for healthcare providers as it increases the risk of certain disease states,” said Dr. David Silver, Chief Medical Officer at Targeted Medical Pharma Inc. and co-author of the report. “For over a decade, our Company has focused on developing amino acid based medical foods like AppTrim specifically designed to manage the distinct nutritional deficiencies associated with obesity.”
Research shows that amino acids and neurotransmitters help to regulate appetite, satiety and body weight, and that an imbalance in these substances can be a contributing factor to the problem of obesity. “Clinicians who are developing obesity management programs for their patients should take into account the specific amino acid and nutrient deficiencies that compromise an obese individuals ability to control appetite and food intake,” said Dr. Lynette Gebler, the principal author of the report. “Correcting the dietary deficiencies and establishing a targeted diet and exercise regimen in addition to a medical food like AppTrim may be very beneficial for obese patients.”
About Targeted Medical Pharma, Inc.
Targeted Medical Pharma, Inc. (OTCQB:TRGM) is a biotechnology company that is committed to drug discovery and development. The company currently develops and distributes amino acid based medical foods, a rapidly growing sector of medication technology, for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders using the patented system of Targeted Cellular Technology.